256 related articles for article (PubMed ID: 9521421)
21. N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.
Parkinson-Lawrence EJ; Muller VJ; Hopwood JJ; Brooks DA
Clin Chim Acta; 2007 Feb; 377(1-2):88-91. PubMed ID: 17027703
[TBL] [Abstract][Full Text] [Related]
22. Mucopolysaccharidosis IVA within Tunisian patients: Confirmation of the two novel GALNS gene mutations.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ferchichi S; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2012 Jun; 60(3):190-2. PubMed ID: 22078177
[TBL] [Abstract][Full Text] [Related]
23. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
[TBL] [Abstract][Full Text] [Related]
24. Descriptively quantitative relationship between mutated N-acetylgalactosamine-6-sulfatase and mucopolysaccharidosis IVA.
Yan S; Wu G
Biopolymers; 2009; 92(5):399-404. PubMed ID: 19373925
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.
Sukegawa K; Nakamura H; Kato Z; Tomatsu S; Montaño AM; Fukao T; Toietta G; Tortora P; Orii T; Kondo N
Hum Mol Genet; 2000 May; 9(9):1283-90. PubMed ID: 10814710
[TBL] [Abstract][Full Text] [Related]
26. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
[TBL] [Abstract][Full Text] [Related]
27. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
[TBL] [Abstract][Full Text] [Related]
28. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations.
Clarke LA; Nelson PV; Warrington CL; Morris CP; Hopwood JJ; Scott HS
Hum Mutat; 1994; 3(3):275-82. PubMed ID: 8019563
[TBL] [Abstract][Full Text] [Related]
30. Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease.
Fateen EM; El Mawgoud HA; Eissa NR; Ibrahim MM; Aglan MS; Essawi ML
Gene; 2017 Feb; 600():48-54. PubMed ID: 27825773
[TBL] [Abstract][Full Text] [Related]
31. Novel missense mutation in the GALNS gene in an affected patient with severe form of mucopolysaccharidosis type IVA.
Seyedhassani SM; Hashemi-Gorji F; Yavari M; Mirfakhraie R
Clin Chim Acta; 2015 Oct; 450():121-4. PubMed ID: 26276046
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel missense mutation in Brazilian patient with a severe form of mucopolysaccharidosis type IVA.
Kubaski F; Brusius-Facchin AC; Palhares HM; Balarin MA; Viapiana-Camelier M; Guidobono R; Burin MG; Giugliani R; Leistner-Segal S
Gene; 2013 Mar; 517(1):112-5. PubMed ID: 23313879
[TBL] [Abstract][Full Text] [Related]
33. Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene.
Tomatsu S; Montaño AM; Lopez P; Trandafirescu G; Gutierrez MA; Oikawa H; Nishioka T; Vieira MB; Orii T; Noguchi A
Mol Genet Metab; 2006; 89(1-2):139-49. PubMed ID: 16837223
[TBL] [Abstract][Full Text] [Related]
34. Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations.
Garrido E; Chabás A; Coll MJ; Blanco M; Domínguez C; Grinberg D; Vilageliu L; Cormand B
Mol Genet Metab; 2007; 92(1-2):122-30. PubMed ID: 17643332
[TBL] [Abstract][Full Text] [Related]
35. Mucopolysaccharidosis IVA: submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease.
Fukuda S; Tomatsu S; Masuno M; Ogawa T; Yamagishi A; Rezvi GM; Sukegawa K; Shimozawa N; Suzuki Y; Kondo N; Imaizumi K; Kuroki Y; Okabe T; Orii T
Hum Mutat; 1996; 7(2):123-34. PubMed ID: 8829629
[TBL] [Abstract][Full Text] [Related]
36. Identification of 12 novel mutations and two new polymorphisms in the arylsulfatase A gene: haplotype and genotype-phenotype correlation studies in Spanish metachromatic leukodystrophy patients.
Gort L; Coll MJ; Chabás A
Hum Mutat; 1999; 14(3):240-8. PubMed ID: 10477432
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of mucopolysaccharidosis IVA (Morquio A) in Spain.
Pajares S; Alcalde C; Couce ML; Del Toro M; González-Meneses A; Guillén E; Pineda M; Pintos G; Gort L; Coll MJ
Mol Genet Metab; 2012 Jun; 106(2):196-201. PubMed ID: 22521955
[TBL] [Abstract][Full Text] [Related]
38. Mucopolysaccharidosis IVA: a novel splice acceptor site mutation in intron 4 of the N-acetylgalactosamine-6-sulfate sulfatase gene in an Afghanistan girl with classical Morquio disease.
Fukuda S; Yamada N; Tomatsu S; Sukegawa K; Montaño AM; Hopwood JJ; Muller V; Orii T; Kondo N
Jpn J Hum Genet; 1997 Jun; 42(2):317-22. PubMed ID: 9290256
[TBL] [Abstract][Full Text] [Related]
39. Effect of 'attenuated' mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase.
Montaño AM; Sukegawa K; Kato Z; Carrozzo R; Di Natale P; Christensen E; Orii KO; Orii T; Kondo N; Tomatsu S
J Inherit Metab Dis; 2007 Oct; 30(5):758-67. PubMed ID: 17876718
[TBL] [Abstract][Full Text] [Related]
40. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease.
Tomatsu S; Orii KO; Vogler C; Nakayama J; Levy B; Grubb JH; Gutierrez MA; Shim S; Yamaguchi S; Nishioka T; Montano AM; Noguchi A; Orii T; Kondo N; Sly WS
Hum Mol Genet; 2003 Dec; 12(24):3349-58. PubMed ID: 14583446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
